Napa9-SPG

N/A

Report date: 2025/01/26 19:10:37
NME

Base Information

Drug NameNapa9-SPG
Drug Alias NameTLR-9 agonist oligonucleotide (NapaJen Pharma)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNapajen Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNapajen Pharma
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A